Neuropathix, Inc. (NPTX) Featured in Virtual Coverage of the LD Micro Main Event
Neuropathix, Inc. (OTCQB: NPTX) is a biopharmaceutical company focused on the research and development of a pipeline of next generation socially responsible pain management and neuroprotective therapeutics to treat patients with significant unmet medical needs. Over the past ten years, Neuropathix has discovered, developed and patented a global intellectual property estate, led by its lead clinical target, KLS-13019, as novel new therapeutic agents designed to…